Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuss

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Journal of Neuro-Oncology|January 30, 2023
Updates on the WHO diagnosis of IDH-mutant gliomaDavid E Reuss
Expert Opinion on Medical Diagnostics|March 19, 2013
Biomarkers for malignant peripheral nerve sheath tumoursD E Reuss, A von Deimling
Clinical Advances in Hematology & Oncology : H&O|October 2, 2020
Immunotherapy for mesothelioma: rationale and new approachesJoshua E Reuss, Patrick M Forde
The Journal of Reproductive Medicine|September 8, 2001
Atypical glandular cells of undetermined significance. Subtyping as a predictor of outcomeE Reuss, J Price, P Koonings
Endocrinology|June 20, 2002
Prenatal LHRH neurons in nasal explant cultures express estrogen receptor beta transcriptNeda Sharifi, Andree E Reuss, Susan Wray
Current Oncology Reports|May 17, 2020
Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and BeyondJoshua E Reuss, Karthik Suresh, Jarushka Naidoo
Neuropathology and Applied Neurobiology|March 16, 2017
WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumoursF Sahm, D E Reuss, C Giannini
Annual Review of Medicine|October 26, 2018
PD-1 Blockade in Early-Stage Lung CancerSamuel Rosner, Joshua E Reuss, Patrick M Forde
Clinical Advances in Hematology & Oncology : H&O|May 28, 2024
Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?Joshua E Reuss, Samuel Rosner, Benjamin P Levy
Clinical Lung Cancer|August 23, 2021
Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future DevelopmentsJoshua E Reuss, Laura Gosa, Stephen V Liu
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Journal of Neuro-Oncology|January 30, 2023
Updates on the WHO diagnosis of IDH-mutant gliomaDavid E Reuss
Expert Opinion on Medical Diagnostics|March 19, 2013
Biomarkers for malignant peripheral nerve sheath tumoursD E Reuss, A von Deimling
Clinical Advances in Hematology & Oncology : H&O|October 2, 2020
Immunotherapy for mesothelioma: rationale and new approachesJoshua E Reuss, Patrick M Forde
The Journal of Reproductive Medicine|September 8, 2001
Atypical glandular cells of undetermined significance. Subtyping as a predictor of outcomeE Reuss, J Price, P Koonings
Endocrinology|June 20, 2002
Prenatal LHRH neurons in nasal explant cultures express estrogen receptor beta transcriptNeda Sharifi, Andree E Reuss, Susan Wray
Current Oncology Reports|May 17, 2020
Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and BeyondJoshua E Reuss, Karthik Suresh, Jarushka Naidoo
Neuropathology and Applied Neurobiology|March 16, 2017
WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumoursF Sahm, D E Reuss, C Giannini
Annual Review of Medicine|October 26, 2018
PD-1 Blockade in Early-Stage Lung CancerSamuel Rosner, Joshua E Reuss, Patrick M Forde
Clinical Advances in Hematology & Oncology : H&O|May 28, 2024
Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?Joshua E Reuss, Samuel Rosner, Benjamin P Levy
Clinical Lung Cancer|August 23, 2021
Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future DevelopmentsJoshua E Reuss, Laura Gosa, Stephen V Liu
Pageof 14